\n\u00cen aceast\u0103 perioad\u0103, pia\u0163a total\u0103 a medicamentelor care se elibereaz\u0103 cu prescrip\u0163ie medical\u0103 \u00een \u0163ara noastr\u0103 a sc\u0103zut cu aproximativ 11%, conform datelor companiilor de studii de pia\u0163\u0103. \u00cen Rom\u00e2nia, industria farmaceutic\u0103 sus\u0163ine sistemul de s\u0103n\u0103tate, 1 din 5 pacien\u0163i primind tratament datorit\u0103 taxei clawback. Pentru a asigura corectitudinea datelor cu privire la taxa clawback, Roche Rom\u00e2nia solicit\u0103 \u00eenc\u0103 o dat\u0103 autorit\u0103\u0163ilor competente s\u0103 \u00eentreprind\u0103 toate diligen\u0163ele necesare pentru a audita datele disponibile la Casa Na\u0163ional\u0103 de Asigur\u0103ri de S\u0103n\u0103tate, cu sprijinul unei institu\u0163ii independente.<\/p>\n
\n\u201cAvem \u00een vedere orice demers legal care ar putea fi necesar pentru a verifica acurate\u0163ea datelor, inclusiv posibile discu\u0163ii cu organele de anchet\u0103 competente. Dorim s\u0103 ne asigur\u0103m c\u0103 datele pe baza c\u0103rora este calculat\u0103 taxa clawback sunt corecte \u015fi comunicate transparent\u201d, a declarat Martine Draullette, General Manager al Roche Rom\u00e2nia.<\/p>\n
\nTaxa clawback a fost introdus\u0103 \u00een anul 2009, \u00een contextul crizei economice, ca o m\u0103sur\u0103 temporar\u0103 pentru de a ar\u0103ta solidaritate \u00eentr-un moment dificil pentru economia Rom\u00e2niei. Astfel, produc\u0103torii de medicamente acoper\u0103 deficitul de finan\u0163are pentru consumul de medicamente. \u00cen situa\u0163ia actual\u0103 \u00eens\u0103, av\u00e2nd \u00een vederea cre\u015fterea economic\u0103 constant\u0103 a Rom\u00e2niei, motivul men\u0163inerii acestei taxe a disp\u0103rut.<\/p>\n
\nRoche Romania sus\u0163ine introducerea unor alte mecanisme care s\u0103 asigure distribuirea echitabil\u0103 a responsabilit\u0103\u0163ilor privind modul \u00een care este finan\u0163at consumul real de medicamente \u00een Rom\u00e2nia, ceea ce ar asigura transparen\u0163\u0103 \u015fi predictibilitate.Pe de alt\u0103 parte, o condi\u0163ie obligatorie pe care statul rom\u00e2n ar trebui s\u0103 o \u00eendeplineasc\u0103 pentru a asigura accesul cet\u0103\u0163enilor s\u0103i la tratamentele de care ace\u015ftia au nevoie, este cre\u015fterea bugetului pentru medicamente, \u00eenghe\u0163at din anul 2012. Pacien\u0163ii din Rom\u00e2nia trebuie s\u0103 se bucure de acelea\u015fi drepturi ca cei din celelalte \u0163\u0103ri ale Uniunii Europene. Finan\u0163area s\u0103n\u0103t\u0103\u0163ii trebuie privit\u0103 ca o investi\u0163ie, care va asigura pe termen lung cre\u015ftere economic\u0103 \u015fi o societate s\u0103n\u0103toas\u0103.<\/p>\n","protected":false},"excerpt":{"rendered":"
Compania Roche Rom\u00e2nia \u00ee\u015fi manifest\u0103 \u00eengrijorarea cu privire la cre\u015fterea inexplicabil\u0103 a valorii taxei clawback \u00een primul trimestru al anului 2017, comparativ cu ultimul trimestru al anului 2016, p\u00e2n\u0103 la 19,86% din valoarea medicamentelor decontate de autorit\u0103\u0163i \u00een primele trei luni ale anului. <\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[510],"tags":[7467,10313,24895,272,201,31832,9817,246,190,21295,17052,472,17725,14862,20977,323,19981,60,23630,98,10758,34613,465],"class_list":["post-147172","post","type-post","status-publish","format-standard","hentry","category-actualitate","tag-asigurare","tag-autoritati","tag-clawback","tag-companie","tag-companii","tag-competente","tag-consum","tag-crestere","tag-crestere-economica","tag-decontare","tag-eliberare","tag-finantare","tag-ingrijorare","tag-introducere","tag-manifestare","tag-medicamente","tag-perioada","tag-piata","tag-prescriptie","tag-romania","tag-taxa","tag-taxa-clawback","tag-valoare"],"_links":{"self":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/147172","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=147172"}],"version-history":[{"count":0,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/147172\/revisions"}],"wp:attachment":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=147172"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=147172"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=147172"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}